{"name":"Qu Biologics Inc.","slug":"qu-biologics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPMGhPdGxVQ2ZhVEN3MkFUXy1rb0VSR3Y3Y3FuWXhzVWdMVmVkdkpHZnZXMWRHcnAyeEVUTVN0X09tRDA3bVdtR2M4M1lVNFo5UXNWWjEzRkNoSjBJS0llaXZNV0VSaEFqOFpvcjFoa0paYkNCZi1HdGR4OHBVY2Y4eGFTNWNLUzFkaHgydjNSRkxiNDdsU2c1WWl1elI0aUNfRmh2c0xYMENfZ0oteDk5c1hRY0swVjVkMjJaMF93eGpSaTBnVFJETjNxMFpSOUx0c1Z5N0VBdlFjYzlpNnhrcGxBbFAzZ20ycVE?oc=5","date":"2025-04-15","type":"pipeline","source":"PR Newswire","summary":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire","headline":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQYTMyOXE3LUVQQnBEeElmbmZncW9jdFlmN1diaW93RnZIcENicFEtNWlnUUlGYTczV3UyOF83UGJVQk1lbGI3eWtEWVc1TWtUNk1RUzNHQVljRjN6cTFnODd5VnJJSUhzM1dTbldiNWVzQXdVN1NFeTF3aU9nenNCZ2pjaS1IT3NxN3FSTUtEZ1hrc3ROMmNpR2VGTU9yVjEyQWVIdnkxT25xMTI0WWt5d1NsWndVaFhwWFRFMWR3UVRBSGNNSWVZ?oc=5","date":"2024-09-03","type":"pipeline","source":"Healio","summary":"Filgotinib maintains remission, improves quality of life over 4 years in UC - Healio","headline":"Filgotinib maintains remission, improves quality of life over 4 years in UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOek9ob3dxS1liUUZfSG9iMjBhX21oVmJGbXAxQVVtVFV5Uk1rRE1ialhpYUZQbEtHZjZZc1lQSEY4LW40WkFqOWlUUzJfUDFCQ2tjRi1WRkpVNHlENTdMNldRZmdBYnQxT2NXb3BxdXlDclA2LXBia2NTNW9MeHRud3VNTTJQbDIzTFdEekdwTlUwcjR3RVNzNU1kUmJDempXWWlidWZvSndwTDZFai0wQVhQdHJ2bXl5QjJCMkJfRFJtZXRaWmRhS2FzeDNoX3VaMjlkTnBsbjg?oc=5","date":"2024-07-23","type":"patent","source":"BioSpace","summary":"Inflammatory Bowel Disease Market to Reach a CAGR of 2.76% during 2024-2034, Impelled by Biologic and Biosimilar Drugs - BioSpace","headline":"Inflammatory Bowel Disease Market to Reach a CAGR of 2.76% during 2024-2034, Impelled by Biologic and Biosimilar Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNMVBaRmxTUlZYYlVWSDVjcTktZFljZjFfcE9VbDlMR29mYUNmdGhENU1KMTRoVG1NcnVtUVphMnJuMXB0V0tCb1ZGVFZIOVFPMDBjQ3NNTC1ETWdnOFJGTy12Y2VJM1VLbDZzYlQ0bmlGRlhBb0Y0dlpPZ2hwb213TW01Z1RETzBBTU9vbFdtcjhaZHdMZERpbWlRQ0dCa2c1SVB2MXVkWjJrSXk5V0Z4Z1VneTlreEFEX0h2dW54NGpnRGt0a29fLW5xZEZoMDg4V0dDRGhvMDV1Q3hmQTlNcmJieVBmTEdoRXlvZ0hvcXdqbDdFazdMSGEwSU4yQkFGdVg4R1Nla3lXQ19hOUtwX0lJZVlBLTFVQkpF?oc=5","date":"2024-07-15","type":"regulatory","source":"PR Newswire","summary":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight - PR Newswire","headline":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Disea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxNY2Jlc3NRQXh3MF9ueV9RZU5peHRxNjZnTGVxZG9YRHJrV2E3c0xERlNQNGxtNS11Zlp2SmlXSmk1cjlvbHBkQm9vWVQ4RVZ4X05rMXlPa190bjlLbXhja3BxWTNOcm5KYi1WWU9SdkpRNVdDLUV0YmNIQWhqOU56c0UtcEFrOEl3QklyMGZUTFQxLUJ2M1llc2tMLURqandNRGRuWktpVVV0WVVLMmVkU21qU29wX2gtcGhTQVRoT3BvRWNLdHQ0Z1ZDZWRHQlBZa2lMLW5WQ2szcHpiUjNtaUNfTjFGZWMtQ0Z3S3ZkR0dEeEVVblU3UG9kQXNXb0l6VnNNUVRxVXl0d0pYTUF5bG54WjNfbmljNmVDYlRkVzQ0MWZGRnBmV2l4RzRXVUJrWWhweGFIZVV1Q01nc1BEVnRlbmJ1TFU?oc=5","date":"2024-06-07","type":"pipeline","source":"GlobeNewswire","summary":"Seniors in Metro Vancouver Invited to Participate in a - GlobeNewswire","headline":"Seniors in Metro Vancouver Invited to Participate in a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOUHY1MWppcXM1ZjJHcnk2S0xIOTFkT3p1eVcyQXI5eE1kMjAzd094ZXF0WjJSQWtIRFk2QmlWLUxYZUlNQy05R2d3X3dKUTlDSlNqREs3QlhkZldjWGthcmQzeU94eFNJbzVHak41T2h5U2hnMmtnbzFkRW1jOGRSSExuRjNPaF8yWENKdU8zbGd1LU9lZU52NEVXc0ZpeU9GNktrYkM4bmF3bFVDc1JFSGk4ZUJIR3JDd0podUZqam1oRE9UdTNqYV9XMlNoSDBfSlZSWjlIOUlWRlV6NTYtMm9WelVJeGZPVXZkV1pibUtYTmpiWS1QcGJsQUlucEl3X293NXpvY1RESDBhN0J1cFM4VQ?oc=5","date":"2024-06-06","type":"pipeline","source":"GlobeNewswire","summary":"Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer - GlobeNewswire","headline":"Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}